Nicolas C Turner

35PUBLICATIONS

374CO-AUTHORS

Medical genetics (excl. cancer genetics)Molecular targetsCancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (35)

Sort by Publication Date:

|Jun 18, 2026

Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline.

|May 19, 2026

Exploratory analysis of PTEN deficiency by immunohistochemistry from the Phase III CAPItello-291 trial.

|Mar 31, 2026

Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER<sup>+</sup> HER2<sup>-</sup> locally-advanced or metastatic breast cancer.

Jackson Liang, Christy Ong, Kareem Heslop

|Mar 04, 2026

Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.

Anton Safonov, Minna Lee, David N Brown

|Feb 18, 2026

LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma.

Renée L Flaherty, Flavia Hughes, George Sflomos

|Oct 29, 2025

The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial.

Iseult M Browne, Javier Pascual, Rosalind J Cutts

Pageof 6

Frequent Collaborators

Mafalda Oliveira

Cristina Saura

Komal L Jhaveri

Lucy S Kilburn

Andrew Wardley

Iain R Macpherson

Miguel Martín

Rosalind J Cutts

Violeta Serra

Judith M Bliss

Frequent Collaborators

Mafalda Oliveira

Cristina Saura

Komal L Jhaveri

Lucy S Kilburn